GFAP gene expression is altered in young rats following developmental low level lead exposure. 1998

S Partl, and H Herbst, and F Schaeper, and A Mohnhaupt, and G Stoltenburg-Didinger
Department of Neuropathology, University Hospital Benjamin Franklin, Freie Universitaet Berlin, Germany.

The astroglia cytoskeletal element, glial fibrillary acid protein GFAP, is a generally accepted sensitive indicator for neurotoxic effects in the mature brain. We used GFAP RNA as a marker for molecular biological changes in rat brain related to chronic low level lead exposure during the developmental period. Brains in the third week of postnatal life, following a continuous prenatal and postnatal exposure to lead of low dose were investigated. Sections were processed for in situ hybridization with a 35S labeled riboprobe, which is specific for mouse GFAP RNA. Radioactive signals which resulted from the RNA-RNA-hybridization process, were achieved by exposure of the sections to X-ray film. The gray values on the X-ray films were investigated by a computer assisted image analyzer system. Our data show that low level lead exposure affects the GFAP RNA-amount. Interestingly these effects were spatially diverse and different in the brain regions investigated. The gray values were significantly enhanced in the CA1 and CA2 regions of the hippocampus, in the striatum and in the cerebellum. The GFAP gene expression seems to reflect the reaction of the astroglia in accordance to the electrophysiological functions of the NMDA receptor in the diverse brain regions and their alterations following low level lead exposure.

UI MeSH Term Description Entries
D007855 Lead Poisoning Poisoning that results from chronic or acute ingestion, injection, inhalation, or skin absorption of LEAD or lead compounds. Poisoning, Lead,Lead Poisonings,Poisonings, Lead
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D005260 Female Females
D005904 Glial Fibrillary Acidic Protein An intermediate filament protein found only in glial cells or cells of glial origin. MW 51,000. Glial Intermediate Filament Protein,Astroprotein,GFA-Protein,Glial Fibrillary Acid Protein,GFA Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000833 Animals, Suckling Young, unweaned mammals. Refers to nursing animals whether nourished by their biological mother, foster mother, or bottle fed. Animal, Suckling,Suckling Animal,Suckling Animals
D001345 Autoradiography The making of a radiograph of an object or tissue by recording on a photographic plate the radiation emitted by radioactive material within the object. (Dorland, 27th ed) Radioautography
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

S Partl, and H Herbst, and F Schaeper, and A Mohnhaupt, and G Stoltenburg-Didinger
October 1992, Physiology & behavior,
S Partl, and H Herbst, and F Schaeper, and A Mohnhaupt, and G Stoltenburg-Didinger
July 1994, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
S Partl, and H Herbst, and F Schaeper, and A Mohnhaupt, and G Stoltenburg-Didinger
October 2010, Toxicology and applied pharmacology,
S Partl, and H Herbst, and F Schaeper, and A Mohnhaupt, and G Stoltenburg-Didinger
January 1987, Neurotoxicology,
S Partl, and H Herbst, and F Schaeper, and A Mohnhaupt, and G Stoltenburg-Didinger
July 2015, Toxicology letters,
S Partl, and H Herbst, and F Schaeper, and A Mohnhaupt, and G Stoltenburg-Didinger
May 1995, Brain research. Developmental brain research,
S Partl, and H Herbst, and F Schaeper, and A Mohnhaupt, and G Stoltenburg-Didinger
March 1999, Neurochemical research,
S Partl, and H Herbst, and F Schaeper, and A Mohnhaupt, and G Stoltenburg-Didinger
August 1984, Toxicology letters,
S Partl, and H Herbst, and F Schaeper, and A Mohnhaupt, and G Stoltenburg-Didinger
January 1978, Journal of environmental pathology and toxicology,
S Partl, and H Herbst, and F Schaeper, and A Mohnhaupt, and G Stoltenburg-Didinger
June 2008, PloS one,
Copied contents to your clipboard!